agglomerin-a and tetronic-acid

Significant developments in the isolation of tetramic acids and tetronic acids, in the elucidation of their biosyntheses and their biological activities and in laboratory syntheses are reviewed with a focus on those derivatives with medicinal and pharmacological relevance. Important new members of the title compound families isolated since the year 2000 are covered as well as new biological aspects of some earlier congeners.

Topics: Animals; Biology; Furans; Humans; Peptides; Pyrrolidinones; Structure-Activity Relationship

The enzyme inhibitor RK-682 (5R)-(+)-1 was prepared in solution and on a solid support from (2R)-glycerates in five steps and ca. 40% overall yield. Key steps were a ring-closing tandem addition-Wittig alkenation reaction of the respective protected or immobilized glycerates with the ylide Ph(3)PCCO and the 3-acylation of the tetronic acids thus obtained with palmitic acid. A similar route extended by a mesylation-elimination sequence led to antibiotic agglomerins A-C 2 featuring 3-acyl-5-methylidenetetronic acid structures.

Topics: 4-Butyrolactone; Acylation; Anti-Bacterial Agents; Enzyme Inhibitors; Furans; Glyceric Acids; Molecular Structure; Palmitic Acid; Phosphoprotein Phosphatases